Pricing Log in Create free account

City Therapeutics, Inc (CTY) vs Janux Therapeutics, Inc. (JANX)

City Therapeutics, Inc and Janux Therapeutics, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. is the larger, with a market value of $981.9M against $882.9M — 1.1× the size.

Valuation

Metric CTY JANX Biotechnology median
P/E — n/m 10.60
P/S — 33.41 9.40
P/B — 1.22 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 5.00 9.02
Earnings yield — (9.02%) (32.88%)
Free cash flow yield — (4.87%) (23.13%)

Profitability

Metric CTY JANX Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (419.24%) 0.00%
Net margin — (299.95%) 0.00%
Free cash flow margin — (162.70%) 0.00%
Return on equity — (10.58%) (51.96%)
Return on assets — (9.94%) (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CTY JANX Biotechnology median
Revenue growth (TTM) — 214.40% 6.76%
EPS growth (last fiscal year) — (42.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTY JANX Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 17.69 4.97
Net debt to EBITDA — 5.58 1.01

Dividend

Metric CTY JANX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTY JANX Biotechnology median
Market cap 882.88m 981.86m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack